Physician leader from Fenway Health in Boston joins the growing clinical team to fight ongoing health crises
BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) — Primary.Health today announced the appointment of Aditya Chandrasekhar as the company’s new medical director where he is responsible for leading Primary.Health’s clinical thought leadership. His role is focused on identifying ways in which direct clinical services can complement existing Primary.Health workflows and enable provider partners and clients to better and faster build clinical teams to help achieve that.
“I’m honored to join Primary.Health and support them on their mission of helping to prevent the spread and reduce the severity of illnesses at-scale,” said Chandrasekhar. “As an experienced physician leader, with a passion for community medicine and public health, their mission resonates with me deeply. I’m looking forward to leading the company’s medical guidance and how together we can address health disparities across large populations.”
Primary.Health added the following individuals to its leadership team and board:
Chandrasekhar has been a Lead Physician at Fenway Health since 2016. Dr. Chandrasekhar earned his MD from Grant Medical College in Mumbai, India, and his MPH from the Johns Hopkins Bloomberg School of Public Health. Dr. Chandrasekhar completed his Internal Medicine Residency at the University of Massachusetts Medical School. He is a Linde Fellow in Primary Care Leadership at Beth Israel Deaconess Medical Center and an Instructor in Medicine at Harvard Medical School. Dr. Chandrasekhar’s areas of clinical interest include LGBTQIA+ health and HIV care.
The new medical director is focused on providing guidance to emerging health threats, and most immediately, developing strategy around Monkeypox. He has actively worked on staying ahead of the curve in regards to Monkeypox trying to predict the ways in which Monkeypox could affect school systems and developing recommendations to contain its spread. Chandrasekhar is utilizing his 8 years of experience dealing with public health issues to create structure for schools as we quickly approach back-to-school.
“Adi’s shared passion for public health and his expertise in the area is just what we need to build our clinic team and support our provider partners with development of protocols for emerging diseases and new diagnostics,” said Andrew Kobylinski, CEO and Founder, Primary.Health. “He is a talented physician who offers Primary.Health, our provider partners, and our customers even more knowledge of infectious diseases. We are excited to work with him as we continue to serve our communities where they need us most.”
To learn more about Primary.Health, please visit: https://primary.health/
About Primary.Health
Primary.Health was born of a volunteer effort in a little California town to protect the health of one community, and we have grown into a company committed to protecting the health of every community through easy and affordable access to diagnostics. We provide program management software and program design services that let employers, schools, and communities administer testing and vaccination to comply with government guidelines and follow the recommendations of healthcare professionals. Through our work with the largest, most complex organizations at the height of the pandemic, Primary has earned the experience and trust to provide superior diagnostic testing for COVID-19, flu, and other conditions that threaten population health. Contact us today to learn more at https://primary.health/.
Media Contacts:
Ali Nix
(339) 227-0583
primary.health@highwirepr.com
BEIJING--(BUSINESS WIRE)--Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered…
Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF…
SOUTH SAN FRANCISCO, Calif., June 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO),…
Vancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology…
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX,…
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX:…